NIH-funded research R01 grant

UTR variants in neurodevelopmental disorders: a fast track to understanding autism biology

Official title: HIGHLY PARALLEL ANALYSIS OF 5' AND 3' UTR VARIANTS IN NEURODEVELOPMENTAL DISORDERS

Funded at Washington University · NIH-11308240 · Data updated 2026-11-12

A research project at Washington University aims to understand how non-coding UTR regions of genes influence autism-related conditions by testing many variants in brain-relevant cells.

More Neurodevelopmental Disorders research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startJune 19, 2018
Project endJanuary 31, 2029
Funding year2026
Award (this year)$775,004
NIH project number5R01MH116999-08
Project IDNIH-11308240 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with autistic disorder or related neurodevelopmental conditions who may contribute samples or benefit from improved genetic understanding in the future.

Less likely to help

Participants not directly affected by autism or those without related genetic findings may not experience immediate benefits.

What this research studies

This project focuses on untranslated regions (UTRs) of mRNAs that regulate protein production in brain cells. Researchers will use massively parallel reporter assays and cell-type specific translation profiling to identify UTR mutations that change protein levels in neural contexts. The goal is to build a pipeline that links specific UTR variants to functional consequences in neurodevelopmental disorders like autism, paving the way for better understanding and potential future interventions. The work involves human disease relevance, brain-relevant cell models, and high-throughput functional testing to interpret non-coding genetic variation.

Why it matters

Potential benefit: If successful, this work could clarify which non-coding variants contribute to autism, guiding future diagnostics and targeted therapies.

How similar studies have gone: Previous projects have shown that non-coding UTR variants can affect gene expression, and this approach extends those findings to neurodevelopmental questions with high-throughput testing.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Dougherty, Joseph D — Washington University
  • Study coordinator: Dougherty, Joseph D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.